Earnings Insights
AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.
How to use these insights
Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.
Hindustan Media Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
Advertising Growth**: Advertising revenue in Print and Radio shows solid growth, with Print up 9% YoY and Radio growing strongly (29% YoY). Key concall…
26 May 2026
Hinduja Global Solutions Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
6,429 crores against debt of Rs. Key concall takeaways from Hinduja Global Solutions Ltd's Q3 FY26 earnings call — and how it ranks against sector peers.
26 May 2026
Hinduja Global Solutions Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
Growth in digital services, with over 55% order pipeline in the Americas and increasing adoption of AI-enabled BPM solutions like Agent X. Key concall…
26 May 2026
Himatsingka Seide Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
market (currently around 60%) and increase revenue from non-U.S. Key concall takeaways from Himatsingka Seide Ltd's Q3 FY26 earnings call — and how it ranks…
26 May 2026
Himatsingka Seide Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
Uncertainties due to incremental tariffs (up to 50%) are impacting sentiments and business environment. Key concall takeaways from Himatsingka Seide Ltd's Q1…
26 May 2026
Hikal Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
The RFP conversion rate is typically between 15% to 20%, with plans to improve this to 20%-25% through enhanced BD efforts. Key concall takeaways from Hikal…
26 May 2026
Hikal Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
The Pharma business has around 12 to 15 products in advanced stages of development and commercialization, up from 6 to 9 the previous year (more than 50%…
26 May 2026
Hikal Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
Crop protection 9M volume growth: 41%, value degrowth: -3.3%; Pharma volume growth: 3.7%, value growth: 7.1%. Key concall takeaways from Hikal Ltd's Q3 FY25…
26 May 2026
Hester Biosciences Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
Poultry healthcare division showing volume-led growth: 18% in Q2 and 10% in H1 FY26. Key concall takeaways from Hester Biosciences Ltd's Q2 FY26 earnings call…
26 May 2026
Hester Biosciences Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
Profit after tax (PAT) grew over 100% last quarter due to improved international performance and margin control. Key concall takeaways from Hester Biosciences…
26 May 2026
Gulshan Polyols Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
2,800 crores in revenue for FY 2027, based on 80%-90% capacity utilization across all divisions, subject to market conditions and OMC allocations. Key concall…
26 May 2026
Gulshan Polyols Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
Revenue grew by 47% year-on-year driven primarily by increased sales in the ethanol segment (Page 3). Key concall takeaways from Gulshan Polyols's Q4 FY25…
26 May 2026
GRP Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
GRP Limited achieved 20% growth in income for Q3 and 9 months of FY25, driven by volume increases in Reclaim and non-Reclaim businesses. Key concall takeaways…
26 May 2026
GPT Infraproject Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
The company’s order book of approximately INR 3,600-3,591 crores is planned to be executed over the next 2.5 years, providing strong revenue visibility. Key…
26 May 2026
GPT Infraproject Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
The current order book stands strong at INR 3,569 crores (almost 3x FY '25 revenues), providing good visibility for future execution. Key concall takeaways…
26 May 2026
GPT Infraproject Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
3,332 crores, translating to about 3.3x FY'24 revenues. Key concall takeaways from GPT Infraproject's Q3 FY25 earnings call — and how it ranks against sector…
26 May 2026
Geojit Fin. Ser. Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
Mutual fund AUM grew 21% in FY '25 to INR14,728 crores; PMS AUM grew 38% to INR1,262 crores, both considered growth areas. Key concall takeaways from Geojit…
26 May 2026
Ganesh Benzoplast Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
The company plans to expand capacity at JNPT by up to 30%-50% through additional land development, possibly increasing storage capacity by approximately 1 to…
26 May 2026
Ganesh Benzoplast Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
Continuous efforts are underway to enhance utilization of terminals (e.g., Goa terminal currently at 30-40% utilization) by exploring new product handling and…
26 May 2026
Frontier Springs Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
Operating leverage from higher capacity utilization and new product introductions (e.g., FIBA system) may improve margins marginally by 1%-2%. Key concall…
26 May 2026